Before you go!

Sign up for the FREE weekly email newsletter from the publishers of American Nurse Today. You’ll get breaking news features, exclusive investigative stories, and more — delivered to your inbox.

Sign up today!

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Take Note - Practice Updates

Drug therapy effective in hepatitis C

A once daily drug combination of sofosbuvir-velpatasvir for 12 weeks resulted in sustained eradication of several genotypes of the hepatitis C virus in 99% of patients in a clinical trial, according to a study in The New England Journal of Medicine. Read more and read the study abstract.

Leave a Reply

You have to agree to the comment policy.


Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing